Glial dysfunction is a common pathological feature of human and experimental models of epilepsy, which is manifested as the expression of microglial pro-inflammatory factors (IL-1β, IL-6, IL-17, TNF-α) in the early stage of epilepsy are significantly upregulated, resulting in impaired neuronal function. Here, IL17A is linked to epilepsy.